dimyristoylphosphatidylserine has been researched along with Protein Aggregation, Pathological in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, JW; Buell, AK; Carozza, J; Dobson, CM; Flagmeier, P; Galvagnion, C; Knowles, TP; Meisl, G; Michaels, TC; Vendruscolo, M | 1 |
1 other study(ies) available for dimyristoylphosphatidylserine and Protein Aggregation, Pathological
Article | Year |
---|---|
β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces.
Topics: alpha-Synuclein; Amino Acid Sequence; beta-Synuclein; Binding, Competitive; Hydrogen-Ion Concentration; Lipids; Phosphatidylserines; Protein Aggregates; Protein Aggregation, Pathological; Protein Binding; Sequence Alignment; Surface Properties | 2016 |